{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:48:40Z","timestamp":1786546120468,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Am J Gastroenterol"],"published-print":{"date-parts":[[2019,2]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>Little is known about how reports on the adverse effects of proton pump inhibitors (PPIs) impact patients' perceptions of these drugs and medication use. We sought to determine patients' level of concern about PPI adverse effects and its association with attempts to discontinue these drugs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This study is an online survey of US adults who use PPIs for gastroesophageal reflux disease. Topics included awareness of and concern about PPI adverse effects, prior discussion with providers, and attempts to stop PPI because of concern about adverse effects. For the primary analysis, we used logistic regression to identify associations between having attempted to stop PPI and concern about PPI-related adverse effects, a provider's recommendation to stop, risk of upper gastrointestinal bleeding (UGIB), age, and gender.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Among 755 patient participants, mean age was 49 years (s.d. 16), 71% were women, and 24% were at high risk of UGIB. Twenty percent of patients were able to write in \u22651 reported adverse effect, and 46% endorsed awareness of \u22651 adverse effect when presented with a list, most commonly chronic kidney disease (17%). Thirty-three percent of patients were slightly concerned, 32% somewhat concerned, and 14% extremely concerned about adverse effects. Twenty-four percent of patients had discussed PPI risks and benefits with a provider, and 9% had been recommended to stop. Thirty-nine percent had attempted to stop their PPI, most (83%) without a provider recommendation. Factors associated with an attempt at stopping PPI included: (i) provider recommendation to stop (odds ratio [OR] 3.26 [1.82\u20135.83]); (ii) concern about adverse effects (OR 5.13 [2.77\u20139.51] for slightly, 12.0 [6.51\u201322.2] for somewhat, and 19.4 [9.75\u201338.7] for extremely concerned); and (iii) female gender (OR 1.64 [1.12\u20132.39]). Patients at high risk of UGIB were as likely to have attempted to stop as others (OR 0.98 [0.66\u20131.44]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Concern about PPIs is common and strongly associated with attempts at discontinuation, even without a provider's recommendation. Notably, individuals at high risk of UGIB, who benefit from PPIs, were equally likely to have tried stopping PPIs as others. Providers should proactively discuss the risks and benefits of PPIs with their patients, who may otherwise make unwise decisions about PPI management on their own.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.14309\/ajg.0000000000000061","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T20:21:32Z","timestamp":1548793292000},"page":"244-249","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":57,"title":["Patients' Perceptions of Proton Pump Inhibitor Risks and Attempts at Discontinuation: A National Survey"],"prefix":"10.14309","volume":"114","author":[{"given":"Jacob E.","family":"Kurlander","sequence":"first","affiliation":[{"name":"VA Ann Arbor Healthcare System, Ann Arbor, MI;"},{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan;"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel H.","family":"Rubenstein","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan;"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan;"},{"name":"Veterans Affairs Ann Arbor Center for Clinical Management Research, Ann Arbor, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline R.","family":"Richardson","sequence":"additional","affiliation":[{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan;"},{"name":"Department of Family Medicine, University of Michigan, Ann Arbor, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Krein","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan;"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan;"},{"name":"Veterans Affairs Ann Arbor Center for Clinical Management Research, Ann Arbor, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"De Vries","sequence":"additional","affiliation":[{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan;"},{"name":"Department of Learning Health Sciences, University of Michigan, Ann Arbor, Michigan;"},{"name":"Center for Bioethics and Social Sciences in Medicine, University of Michigan, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer D.","family":"Saini","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan;"},{"name":"Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan;"},{"name":"Veterans Affairs Ann Arbor Center for Clinical Management Research, Ann Arbor, Michigan;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,1,23]]},"reference":[{"key":"R1-20250611","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999\u20132012","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA"},{"key":"R3-20250611","doi-asserted-by":"crossref","first-page":"e0128004","DOI":"10.1371\/journal.pone.0128004","article-title":"Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: A systematic review and meta-analysis","volume":"10","author":"Lambert","year":"2015","journal-title":"PLoS One"},{"key":"R4-20250611","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1001\/jamainternmed.2015.42","article-title":"Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile infection","volume":"175","author":"McDonald","year":"2015","journal-title":"JAMA Intern Med"},{"key":"R5-20250611","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00198-015-3365-x","article-title":"Proton-pump inhibitors and risk of fractures: An update meta-analysis","volume":"27","author":"Zhou","year":"2016","journal-title":"Osteoporos Int"},{"key":"R6-20250611","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","article-title":"Proton pump inhibitor use and the risk of chronic kidney disease","volume":"176","author":"Lazarus","year":"2016","journal-title":"JAMA Intern Med"},{"key":"R7-20250611","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.gastro.2017.04.047","article-title":"Complications of proton pump inhibitor therapy","volume":"153","author":"Vaezi","year":"2017","journal-title":"Gastroenterology"},{"key":"R8-20250611","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The risks and benefits of long-term use of proton pump inhibitors: Expert review and best practice advice from the American Gastroenterological Association","volume":"152","author":"Freedberg","year":"2017","journal-title":"Gastroenterology"},{"key":"R14-20250611","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1161\/CIRCULATIONAHA.108.191087","article-title":"ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents","volume":"118","author":"Bhatt","year":"2008","journal-title":"Circulation"},{"key":"R16-20250611","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.2196\/jmir.4.2.e13","article-title":"Using the internet for surveys and health research","volume":"4","author":"Eysenbach","year":"2002","journal-title":"J Med Internet Res"},{"key":"R17-20250611","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/jcpt.12371","article-title":"Evidence-based and unlicensed indications for proton pump inhibitors and patients' preferences for discontinuation: A pilot study in a sample of Italian community pharmacies","volume":"41","author":"Pasina","year":"2016","journal-title":"J Clin Pharm Ther"},{"key":"R18-20250611","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/pgmj.2006.051151","article-title":"Inappropriate prescribing of proton pump inhibitors in primary care","volume":"83","author":"Batuwitage","year":"2007","journal-title":"Postgrad Med J"},{"key":"R19-20250611","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/SMJ.0b013e31828db01f","article-title":"Four-year trends of inappropriate proton pump inhibitor use after hospital discharge","volume":"106","author":"Leri","year":"2013","journal-title":"South Med J"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000434-201902000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T13:51:56Z","timestamp":1786542716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201902000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,23]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.14309\/ajg.0000000000000061","relation":{},"ISSN":["0002-9270","1572-0241"],"issn-type":[{"value":"0002-9270","type":"print"},{"value":"1572-0241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,23]]},"assertion":[{"value":"2018-06-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}